Infliximab treatment reduces complement activation in patients with rheumatoid arthritis

Background: Tumour necrosis factor (TNF) blocking agents decrease C reactive protein (CRP) levels in rheumatoid arthritis (RA). It has been shown that CRP may contribute to complement activation in RA. Objective: To assess the effect of intravenous infliximab treatment on complement activation, espe...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Familian, A, Voskuyl, A, van Mierlo, G J, Heijst, H, Twisk, J, Dijkmans, B, Hack, C
Médium: Artigo
Jazyk:Inglês
Vydáno: 2005
Témata:
Extended Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755560/
https://ncbi.nlm.nih.gov/pubmed/15958758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.029124
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky